What Verdica's 799 score means for APOTEX INC
APOTEX INC received a composite score of 799 out of 850, placing it in the "strong" band (740–799). This score reflects compliance performance across three regulatory dimensions tracked by state boards of pharmacy, the FDA, and the DEA. A score in this range indicates that the provider demonstrates solid adherence to applicable licensing, manufacturing, and distribution standards, with no major red flags in the indexed records.
Readers should interpret a 799 score as a positive signal of regulatory standing, though not the highest tier. The entity has not achieved the "excellent" band (800–850), meaning there is room for improvement or minor compliance gaps in at least one measured area. For businesses or consumers evaluating APOTEX INC, this score suggests the provider is operating within acceptable and above-average compliance thresholds, making it a reasonable candidate for further vetting—but it warrants a closer look at the specific sub-score breakdown to understand where strengths and relative weaknesses lie.
How the sub-scores break down
Product Approval (850/850): This perfect score reflects APOTEX INC's full compliance in the product approval dimension. In pharmacy and manufacturing, a maximum score here typically means all marketed products carry valid approvals from the FDA or equivalent regulatory bodies, no recalls are flagged in active data, and documentation of product licensing is current. This is the strongest component of the overall score.
FDA Compliance (830/850): This score indicates solid but not flawless adherence to FDA standards. FDA compliance encompasses facility inspection records, adverse event reporting, Good Manufacturing Practice (GMP) adherence, and product quality metrics. A score of 830 suggests APOTEX INC has maintained acceptable standards in most areas but may have minor inspection findings, corrective action requests, or other non-critical compliance notes on record. This is still well above the "acceptable" threshold and reflects a provider managing regulatory expectations effectively.
Manufacturer Profile (720/850): This is the lowest of the three sub-scores and falls within the "acceptable" band. The Manufacturer Profile dimension typically aggregates state board of pharmacy records, DEA licensing status, ownership history, and operational credentials. A score of 720 does not indicate a critical problem but suggests there may be administrative gaps, licensing complexities, or historical findings that have not fully resolved. This sub-score is the primary driver preventing the overall score from reaching the "excellent" band.
What regulators track for pharmacy providers
State boards of pharmacy maintain detailed records on entity licensing status, disciplinary actions, and operational compliance. They track whether a provider holds active licenses in relevant jurisdictions, whether any licenses have been suspended or revoked, and whether the entity has faced administrative proceedings. Infractions at this level range from minor paperwork oversights to serious violations involving product handling, record falsification, or patient safety failures.
The FDA monitors pharmacy manufacturers and distributors through inspection programs, adverse event reporting systems, and product recall databases. The agency evaluates facility conditions, documentation practices, and quality control measures. Compliance issues that move scores include GMP violations, inadequate contamination controls, incomplete adverse event investigations, or unresolved warning letters.
The DEA tracks controlled substance licensing, inventory management, and diversion prevention. For pharmacy providers, DEA compliance reflects whether the entity holds valid registrations to handle controlled substances and whether any loss, theft, or suspicious order activity has been documented.
Scores move based on the age, severity, and resolution status of findings across these systems. Current, unresolved critical violations lower scores significantly, while resolved minor findings have smaller impacts.
Bottom line
APOTEX INC's 799 score positions it as a strong, above-average provider with solid regulatory standing. The perfect Product Approval score is a positive indicator, though the slightly lower Manufacturer Profile score warrants a direct check of state licensing records and any historical enforcement actions before committing to a business relationship.